Cylera is a healthcare-focused IoT/IoMT asset intelligence and security platform that continuously discovers and inventories connected medical devices, enriches device context and SBoM metadata, assesses vulnerabilities with non-disruptive techniques, and delivers device intelligence into existing security and IT workflows.
Published Aug 13, 2026
No public roadmap with firm dates was found in the sources collected. Organizations should request a product roadmap and planned feature releases during evaluation.
No public, tested-scale metrics (devices per site, events per second, retention policies) were documented in the sources collected. Prospective purchasers should request:
No public evidence of churn drivers was identified in the sources collected. Organizations should obtain customer references during procurement to understand retention and churn reasons.
From vendor-curated materials and limited analyst write-ups, commonly cited reasons for selection include:
These reasons are largely based on vendor-provided materials and limited independent coverage.
Because public review volume is minimal, robust common-complaint analysis cannot be derived from crowdsourced platforms. The explicit criticism identified in public review content was a perception of relatively high price from limited reviewer feedback.
The vendor publishes case studies referencing deployments at large health systems and hospital trusts. Public snippets available in search results did not include full case study contents in the sources captured, so specific metrics and outcomes could not be independently verified in this review.
The vendor has cited placement in an analyst matrix for connected medical device security solutions and has included customer-quoted claims about coverage improvements. Without access to the full analyst report and methodology, these claims should be treated as directional and vendor-mediated.
Based on vendor positioning and cited analyst write-ups, the typical fit is:
Decision makers:
End users:
Get a comprehensive analysis of Cylera including market position, competitive landscape, adoption trends, and peer benchmarks.
Download full report →Cylera has limited presence on mainstream review platforms in the sources captured:
This scarcity of reviews may indicate lower review-platform representation, limited customer posting behavior, or that the vendor has not prioritized review collection. Organizations should treat review-platform absence as a signal to obtain reference calls and direct customer validation.
G2 (single reviewer — paraphrased):
Vendor testimonials (curated and presented in marketing context):
Cylera is a healthcare-focused IoT/IoMT (Internet of Medical Things) asset intelligence and security platform. It is designed to enable healthcare delivery organizations (HDOs) to continuously discover and inventory connected devices, add device context (make/model/OS/services and other attributes), assess vulnerabilities and risk, detect anomalous behaviors and threats from network telemetry, and provide device context to existing security and IT workflows (for example, SIEM, NAC, ITSM/CMDB).
The vendor describes use of patented methods for device context extraction and vulnerability assessment approaches intended to avoid disruptive active scanning; it also describes a threat prioritization mechanism intended to reduce alert volume. These are vendor claims; independent validation in public sources is limited.
Evidence (official product claims): The vendor emphasizes continuous device inventory, device metadata including SBoM attributes, network traffic analysis, and features for identifying and mitigating risk and threats. The platform is described as supporting low-code and API integrations into common security and IT systems and providing a segmentation policy generator.
Cylera is positioned primarily for:
Vendor materials and public commentary indicate a focus on mid-to-large hospitals and multi-facility networks, though adoption by smaller providers may occur depending on pricing and scope. This sizing guidance is vendor-mediated and should be validated during procurement.